Zobrazeno 1 - 10
of 42
pro vyhledávání: '"Suay G"'
Autor:
Suay G; Medical Oncology Department - La Fe Hospital, Valencia, Spain; Biomarker and Precision Medicine Unit - Health Research Institute La Fe Hospital, Valencia, Spain., Garcia-Cañaveras JC; Biomarker and Precision Medicine Unit - Health Research Institute La Fe Hospital, Valencia, Spain., Aparisi F; Medical Oncology Department - La Fe Hospital, Valencia, Spain; Biomarker and Precision Medicine Unit - Health Research Institute La Fe Hospital, Valencia, Spain., Garcia J; Medical Oncology Service, Hospital Arnau Vilanova, Valencia, Spain., Juan-Vidal O; Medical Oncology Department - La Fe Hospital, Valencia, Spain; Biomarker and Precision Medicine Unit - Health Research Institute La Fe Hospital, Valencia, Spain., Lahoz A; Biomarker and Precision Medicine Unit - Health Research Institute La Fe Hospital, Valencia, Spain. Electronic address: agustin.lahoz@uv.es.
Publikováno v:
Cancer letters [Cancer Lett] 2024 Dec 01; Vol. 606, pp. 217317. Date of Electronic Publication: 2024 Nov 01.
Autor:
Carcereny E; Institut Català D'oncologia Badalona- Hospital Germans Trias I Pujol, B-Argo Group, Badalona, Spain. ecarcereny@iconcologia.net., Rodriguez-Abreu D; Hospital Universitario Insular de Gran Canaria, Las Palmas de Gran Canaria, Spain., Lopez R; Hospital Clínico Universitario de Valladolid, Valladolid, Spain., Franco F; Hospital Universitario Puerta de Hierro-Majadahonda, Madrid, Spain., Guirado M; Hospital General Universitario de Elche, Elche, Spain., Massutí B; Hospital General Universitario Dr. Balmis de Alicante, Alicante, Spain., Cobo M; Hospital Regional Universitario de Málaga, Málaga, Spain., Blasco A; Hospital General Universitario de Valencia, Valencia, Spain., Suay G; Hospital Universitari I Politècnic La Fe, Valencia, Spain., Del Barco E; Hospital Universitario de Salamanca, Salamanca, Spain., Ortega AL; Hospital Universitario de Jaén, Jaen, Spain., Sala MA; OSI Bilbao Basurto, Bilbao, Spain., Cordeiro P; Complejo Hospitalario Universitario A Coruña, A Coruña, Spain., Bernabé R; Hospital Universitario Virgen del Rocío, Seville, Spain., González Larriba JL; Hospital Universitario Clínico San Carlos, Madrid, Spain., Bosch-Barrera J; Josep Trueta and Precision Oncology Group (OncoGIR-Pro), Institut d'Investigacions Biomèdiques de Girona (IDIBGI), Catalan Institute of Oncology, Hospital Universitari Dr, Girona, Spain., Calzas J; Hospital Universitario de Fuenlabrada, Fuenlabrada, Madrid, Spain., Casal J; Complejo Hospitalario Universitario de Vigo, Vigo, Spain., Padilla A; Hospital Universitario, Nuestra Señora De La Candelaria, Santa Cruz de Tenerife, Spain., Sánchez-Hernandez A; Hospital Provincial de Castellón, Castellón, Spain., Provencio M; Hospital Universitario Puerta de Hierro-Majadahonda, Madrid, Spain.
Publikováno v:
Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico [Clin Transl Oncol] 2024 Dec; Vol. 26 (12), pp. 3218-3225. Date of Electronic Publication: 2024 Jun 11.
Autor:
Suay G; Medical Oncology Department, Biomarker and Precision Medicine Unit, La Fe University and Polytechnic Hospital, Valencia, Spain., Martín-Martorell P; Medical Oncology Department, University Clinical Hospital, Valencia, Spain., Aparisi F; Medical Oncology Investigator, Biomarker and Precision Medicine Unit, Health Research Institute Hospital La Fe, Valencia, Spain., Arnal M; Medical Oncology Department, Provincial Hospital Consortium, Castellón, Spain., Guirado M; Medical Oncology Department, General University Hospital of Elche, Alicante, Spain., Azkárate A; Medical Oncology Department, Son Espases University Hospital, Palma, Spain., Garde-Noguera J; Medical Oncology Department, Arnau de Vilanova Hospital, Valencia, Spain., Cumplido-Burón JD; Medical Oncology Department, Torrevieja University Hospital, Alicante, Spain., Insa A; Medical Oncology Department, University Clinical Hospital, Valencia, Spain., González-Muñoz JF; Department of Pathology, Biomedical Research Institute INCLIVA, Valencia, Spain., Palanca S; Clinical Analysis Department, Molecular Biology Unit, La Fe University and Polytechnic Hospital, Valencia, Spain., Díaz M; Clinical Analysis Department, Castellón University General Hospital, Castellón de La Plana, Spain., Sánchez-Hernández A; Medical Oncology Department, Provincial Hospital Consortium, Castellón, Spain., Juan-Vidal Ó; Medical Oncology Department, Biomarker and Precision Medicine Unit, La Fe University and Polytechnic Hospital, Valencia, Spain. juan_osc@gva.es.
Publikováno v:
Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico [Clin Transl Oncol] 2024 Nov 05. Date of Electronic Publication: 2024 Nov 05.
Autor:
Suay G; Medical Oncology Department, Biomarkers and Precision Medicine Unit, Health Research Institute Hospital La Fe, Valencia, Spain., Aparisi F; Medical Oncology Department, Biomarkers and Precision Medicine Unit, Health Research Institute Hospital La Fe, Valencia, Spain., Juan-Vidal O; Medical Oncology Department, University and Polytechnic La Fe Hospital, Valencia, Spain.
Publikováno v:
Chinese clinical oncology [Chin Clin Oncol] 2024 Jun; Vol. 13 (3), pp. 46. Date of Electronic Publication: 2024 Feb 20.
Autor:
García-Giménez JL; Department of Physiology, Faculty of Medicine and Dentistry, University of Valencia, 46010 Valencia, Spain.; INCLIVA Health Research Institute, INCLIVA, 46010 Valencia, Spain.; Consortium Center for Biomedical Network Research on Rare Diseases (CIBERER), Institute of Health Carlos III, 46010 Valencia, Spain., Saadi W; Department of Biology, Faculty of Nature, Life and Earth Sciences, University of Djillali Bounaama, Khemis Miliana 44225, Algeria., Ortega AL; Department of Physiology, Faculty of Pharmacy, University of Valencia, 46100 Burjassot, Spain., Lahoz A; Biomarkers and Precision Medicine Unit, Health Research Institute-Hospital La Fe, 46026 Valencia, Spain.; Analytical Unit, Health Research Institute-Hospital La Fe, 46026 Valencia, Spain., Suay G; Medical Oncology Department, Hospital Universitari i Politècnic La Fe, 46026 Valencia, Spain., Carretero J; Department of Physiology, Faculty of Pharmacy, University of Valencia, 46100 Burjassot, Spain., Pereda J; Department of Physiology, Faculty of Pharmacy, University of Valencia, 46100 Burjassot, Spain., Fatmi A; Department of Microbiology & Biochemistry, Faculty of Science, University of M'sila, M'sila 28000, Algeria., Pallardó FV; Department of Physiology, Faculty of Medicine and Dentistry, University of Valencia, 46010 Valencia, Spain.; INCLIVA Health Research Institute, INCLIVA, 46010 Valencia, Spain.; Consortium Center for Biomedical Network Research on Rare Diseases (CIBERER), Institute of Health Carlos III, 46010 Valencia, Spain., Mena-Molla S; INCLIVA Health Research Institute, INCLIVA, 46010 Valencia, Spain.; Department of Physiology, Faculty of Pharmacy, University of Valencia, 46100 Burjassot, Spain.
Publikováno v:
International journal of molecular sciences [Int J Mol Sci] 2024 Feb 01; Vol. 25 (3). Date of Electronic Publication: 2024 Feb 01.
Autor:
Suay, G., Ortiz-Gracia, A., Rodrigo, C., Linares, J., Garcia-Cañaveras, J.-C., Armero, A., Aparisi, F., Lahoz, A., Juan-Vidal, O.
Publikováno v:
Journal of Thoracic Oncology; 2024 Supplement, Vol. 19 Issue 10, pS599-S600, 2p
Autor:
Suay G; Biomarkers and Precision Medicine Unit, Health Research Institute La Fe, Av. Fernando Abril Martorell, 106, 46026 Valencia, Spain., Garcia-Cañaveras JC; Biomarkers and Precision Medicine Unit, Health Research Institute La Fe, Av. Fernando Abril Martorell, 106, 46026 Valencia, Spain., Aparisi F; Biomarkers and Precision Medicine Unit, Health Research Institute La Fe, Av. Fernando Abril Martorell, 106, 46026 Valencia, Spain., Lahoz A; Biomarkers and Precision Medicine Unit, Health Research Institute La Fe, Av. Fernando Abril Martorell, 106, 46026 Valencia, Spain., Juan-Vidal O; Medical Oncology Department, La Fe University and Polytechnic Hospital, Av. Fernando Abril Martorell, 106, 46026 Valencia, Spain.
Publikováno v:
Cancers [Cancers (Basel)] 2023 Sep 06; Vol. 15 (18). Date of Electronic Publication: 2023 Sep 06.
Kniha
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Suay, G, Bataller, L
Publikováno v:
REVISTA DE NEUROLOGIA
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
instname
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
instname
Introduction. Checkpoint inhibitors have dramatically transformed cancer treatment. However, due to the increasing number of tumors in which they are used, there is a high number of reported adverse effects. Among them, we highlight neurological side
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=RECOLECTA___::beabb198ff4809cb979efc4fc9d1f30c
https://fundanet.iislafe.san.gva.es/publicaciones/ProdCientif/PublicacionFrw.aspx?id=10112
https://fundanet.iislafe.san.gva.es/publicaciones/ProdCientif/PublicacionFrw.aspx?id=10112
Autor:
Gironés Sarrió, R., Arnal Rondan, M., Linares, J., Suay, G., Gómez Sepúlveda, N., Ferrero, A., Perea Rojo, J., Caballero, J., Soler, A., Soriano, D., Esteve, J., Soria, E., Gómez Roch, E., Escriva, C., Juan Vidal, Ó.
Publikováno v:
In Journal of Geriatric Oncology October 2022 13(8) Supplement 1:S73-S73